Growth hormone therapy in growth retardation in juvenile idiopathic arthritis

Ewa Gniadek; Jacek Postępski

eISSN: 2084-9834
ISSN: 0034-6233

Reumatologia/Rheumatology

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

2/2010
vol. 48

Send email

Copy url:

abstract:

Original paper

Growth hormone therapy in growth retardation in juvenile idiopathic arthritis

Ewa Gniadek

,

Jacek Postępski

Reumatologia 2010; 48, 2: 112–120

Online publish date: 2010/05/14

View full text Get citation

Growth retardation is a major problem in children suffering from juvenile idiopathic arthritis (JIA), especially those with a systemic and polyarticular course of the disease.
The article reviews the current literature on clinical studies concerned with growth retardation and growth hormone (GH) therapy in children with JIA.
Growth retardation is a result of persistent inflammation in JIA and may be intensified by the adverse effects of glucocorticoid therapy. Current treatment strategies in JIA do not always stop growth retardation, in which case GH therapy is recommended. The best results are achieved when GH is applied before severe growth retardation has appeared.

keywords:

juvenile idiopathic arthritis, growth hormone, growth retardation

EVENTS/KONFERENCJE

BOOKS/KSIĄŻKI

Growth hormone therapy in growth retardation in juvenile idiopathic arthritis

Ewa Gniadek , Jacek Postępski

juvenile idiopathic arthritis, growth hormone, growth retardation

Ewa Gniadek

,

Jacek Postępski